Cerebrospinal fluid neurogranin and YKL‐40 as biomarkers of Alzheimer's disease

OBJECTIVE: Widespread implementation of cerebrospinal fluid (CSF) biomarkers of Alzheimer's disease (AD) in clinical settings requires improved accuracy for diagnosis of prodromal disease and for distinguishing AD from non‐AD dementias. Novel and promising CSF biomarkers include neurogranin, a...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ann Clin Transl Neurol
Asıl Yazarlar: Janelidze, Shorena, Hertze, Joakim, Zetterberg, Henrik, Landqvist Waldö, Maria, Santillo, Alexander, Blennow, Kaj, Hansson, Oskar
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2015
Konular:
Research Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4704480/
https://ncbi.nlm.nih.gov/pubmed/26783546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.266
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller